glycine and glp 1 Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo GLP-1/GIP + Glycine Weight-Loss Injection

Best For: Clients who want faster, more transformative results

Three of our portfolio companies are helping define what that looks like: FlyteHealth, OpenLoop, and Tenovi, an Inc

Support appetite control with Calocurbs 100% natural, plant-based GLP-1 activator on Fullscript

When appetite is suppressed by GLP-1 medications, fruit and vegetable intake is often the first thing to drop

A retrospective analysis of 105,000+ patients revealed: 40% lower OSA risk with tirzepatide (Zepbound) or semaglutide (Wegovy) vs non-AOM users Lower OSA incidence: 3.12% vs 12.56% Comparable impact between tirzepatide and semaglutide, with tirzepatide showing a slight edge after 6 months This study highlights the potential for AOMs to address obesity and OSA, supporting broader healthcare value through comorbidity reduction

This carefully curated starter system combines our most effective products with simple guidance to get you results fast